Clinical Trials
4 trialsNCT02573324 2023-05-11
Intellance1
AbbVie
Phase 3 Completed
NCT01480479 2018-01-16
ACT IV
Celldex Therapeutics
Phase 3 Completed
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00003293 2012-09-11
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Pfizer
Phase 3 Completed